Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

5.5K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.5K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

1.7K
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.7K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

10.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.7K
Internal Receptors01:31

Internal Receptors

76.5K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
76.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

4.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.9K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

19.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ComplexDnet: A Network-Based Strategy to Discover Critical Targets and Screen Active Compounds for Complex Diseases.

Journal of medicinal chemistry·2025
Same author

NADPHnet: a novel strategy to predict compounds for regulation of NADPH metabolism via network-based methods.

Acta pharmacologica Sinica·2024
Same author

A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma.

Journal of immunology research·2022
Same author

Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor.

Acta pharmacologica Sinica·2017
Same author

Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.

Acta pharmacologica Sinica·2017
Same author

Insights into the molecular mechanisms of Polygonum multiflorum Thunb-induced liver injury: a computational systems toxicology approach.

Acta pharmacologica Sinica·2017

Related Experiment Video

Updated: Mar 30, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

6.9K

[Progress in study of selective ERβ ligands].

Jin-ya Cai, Jun-hao Li, Shi-hui Ding

    Yao Xue Xue Bao = Acta Pharmaceutica Sinica
    |November 3, 2015
    PubMed
    Summary

    Selective estrogen receptor beta (ERβ) ligands are crucial for targeting diseases like cancer and osteoporosis. This review summarizes key ERβ ligands and analyzes their structure-activity relationships for therapeutic development.

    More Related Videos

    Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
    14:13

    Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

    Published on: January 1, 2018

    13.9K
    Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
    06:07

    Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

    Published on: June 7, 2020

    5.4K

    Related Experiment Videos

    Last Updated: Mar 30, 2026

    Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
    09:07

    Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

    Published on: December 19, 2018

    6.9K
    Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
    14:13

    Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

    Published on: January 1, 2018

    13.9K
    Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
    06:07

    Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

    Published on: June 7, 2020

    5.4K

    Area of Science:

    • Endocrinology
    • Molecular Biology
    • Pharmacology

    Background:

    • Estrogen receptors (ERs) are nuclear receptors implicated in diseases including cancer, inflammation, and osteoporosis.
    • ERs exist as ERα and ERβ, with distinct functions and distributions.
    • Selective ERβ targeting offers therapeutic advantages by modulating physiological functions while minimizing ERα-related side effects.

    Purpose of the Study:

    • To review various selective ERβ ligands.
    • To analyze the structure-activity relationships of these ligands.

    Main Methods:

    • Literature review of selective ERβ ligands.
    • Analysis of structure-activity relationships.

    Main Results:

    • Summary of different classes of selective ERβ ligands.
    • Identification of key structural features influencing ERβ selectivity and activity.

    Conclusions:

    • Selective ERβ ligands represent a promising therapeutic strategy.
    • Understanding structure-activity relationships is vital for designing potent and selective ERβ modulators.